717 results on '"Arcusa A"'
Search Results
2. The 4.2 ka event is not remarkable in the context of Holocene climate variability
- Author
-
Nicholas P. McKay, Darrell S. Kaufman, Stéphanie H. Arcusa, Hannah R. Kolus, David C. Edge, Michael P. Erb, Chris L. Hancock, Cody C. Routson, Maurycy Żarczyński, Leah P. Marshall, Georgia K. Roberts, and Frank Telles
- Subjects
Science - Abstract
Abstract The “4.2 ka event” is a commonly described abrupt climate excursion that occurred about 4200 years ago. However, the extent to which this event is coherent across regional and larger scales is unclear. To objectively assess climate excursions in the Holocene we compile 1142 paleoclimate datasets that span all continents and oceans and include a wide variety of archive and proxy types. We analyze these data to determine the timing, significance and spatial imprint of climate excursions using an objective method that quantifies local, regional and global significance. Site-level excursions in temperature and hydroclimate are common throughout the Holocene, but significant global-scale excursions are rare. The most prominent excursion occurred 8200 years ago, when cold and dry conditions formed a large, significant excursion centered in the North Atlantic. We find additional significant excursions between 1600 and 1000 years ago, which agree with tree-ring data and annual-scale paleoclimate reconstructions, adding confidence and context to our findings. In contrast, although some datasets show significant climate excursions 4200 years ago, they do not occur in large, coherent spatial regions. Consequently, like most other periods in the Holocene, the “4.2 ka event” is not a globally significant climate excursion.
- Published
- 2024
- Full Text
- View/download PDF
3. Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study
- Author
-
Virginia Lope, Ángel Guerrero-Zotano, Nerea Fernández de Larrea-Baz, Silvia Antolín, Marta Benavent Viñuales, Begoña Bermejo, Emma Ruiz-Moreno, José Manuel Baena-Cañada, Lorena París, Antonio Antón, José Ignacio Chacón, Montserrat Muñoz, José Angel García-Sáenz, Clara Olier, Pedro Sánchez Rovira, Angels Arcusa Lanza, Sonia González, Joan Brunet, Amparo Oltra, Susana Bezares, Libertad Rosell, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Miguel Martín, and Marina Pollán
- Subjects
Breast cancer survivors ,Health-related quality of life ,WCRF/AICR recommendations ,Cancer prevention guidelines ,Health behaviors ,Internal medicine ,RC31-1245 - Abstract
Objectives: Adherence to healthy lifestyle recommendations has been reported to improve health-related quality of life (HRQL) in breast cancer (BC) patients, but the influence of long-term behavioral changes remains unknown. We evaluated the association between adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations and HRQL both, at BC diagnosis and the change 7−12 years later. Design: Prospective cohort study. Settings and participants: A total of 406 breast cancer survivors, from the EpiGEICAM study, were recruited in 16 Spanish hospitals. Measurements: Epidemiological, clinical, dietary, physical activity and HRQL information was collected both at recruitment and 7−12 years later. A 7-item score to measure compliance with recommendations was assessed according to the 2018 WCRF/AICR scoring criteria. HRQL was evaluated using SF-36 questionnaire. Linear mixed models for longitudinal data were used to assess the cross-sectional and longitudinal association between adherence score and the physical and mental component summary scores. Results: At diagnosis, for each unit increase in WCRF/AICR score adherence, the HRQL physical domain increased 0.78 points (95%CI: −0.04 to 1.60; P trend:0.06). The mean change in physical HRQL from diagnosis to follow-up per unit increase in within-subject adherence score was 0.73 points (95%CI: −0.18 to 1.65; P trend: 0.12). For the mental domain, no association was observed with compliance with the recommendations at diagnosis, nor with changes in adherence over time. Conclusions: Our results suggest that Increased adherence to WCRF/AICR cancer prevention recommendations over time could contribute to slightly improved long-term physical HRQoL in BC survivors.
- Published
- 2024
- Full Text
- View/download PDF
4. Piloting a Spanish-Language Web-Based Tool for Hereditary Cancer Genetic Testing
- Author
-
Deborah Cragun, Gretter Manso, Stefania Alastre Arcusa, Brenda Zuniga, Julie Dutil, Marcia Cruz, and Tuya Pal
- Subjects
hereditary cancer ,genetic counseling ,cancer education ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
The delivery of hereditary cancer pre-test education among Spanish-language patients is impeded by the dearth of Spanish-speaking genetic counselors. To address this gap, we evaluated a web-based genetic education tool delivered in Spanish to provide information typically discussed during an initial genetic counseling session. Spanish-speaking patients with a personal or family history of cancer were recruited at two centers in Puerto Rico and through social media. A total of 41 participants completed a survey before and after viewing the tool to measure knowledge, attitudes, and decisional empowerment. A subset of 10 participants completed a virtual semi-structured interview to assess the usability and appropriateness of the tool. Paired t-tests were calculated to evaluate changes in knowledge and attitudes. A McNemar test assessed for decisional empowerment. Interview transcripts were translated from Spanish to English and inductively coded and analyzed. Results revealed significant increases in knowledge (p < 0.001), while attitudes about genetic testing did not change (p = 0.77). The proportion of individuals who felt fully informed and empowered to decide about whether to undergo genetic testing increased from 15% to 51% (p < 0.001). Qualitative data indicated that participants found the tool easy to use with informative and valuable content. Our findings suggest this Spanish-language tool is a user-friendly and scalable solution to help inform and empower many individuals to decide about cancer genetic testing, recognizing that others may still benefit from genetic counseling prior to testing.
- Published
- 2023
- Full Text
- View/download PDF
5. Anthropometric and Body Composition Changes during Pre-Season of Spanish Professional Female Soccer Players According to Playing Position
- Author
-
Marta Ramírez-Munera, Raúl Arcusa, Francisco Javier López-Román, Desirée Victoria-Montesinos, Ana María García-Muñoz, Vicente Ávila-Gandía, Silvia Pérez-Piñero, and Javier Marhuenda
- Subjects
female soccer ,anthropometry ,bioimpedance ,performance ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Background: In professional soccer, body composition analysis is crucial to assess preparation and optimize performance. Different playing positions have different physical demands, which can lead to variations in body composition. However, there are few studies on women’s soccer that consider the playing position. This study aims to fill that gap by examining position-specific differences in anthropometric and body composition characteristics among Spanish professional female soccer players at the beginning and end of pre-season. Furthermore, it investigates the possible changes during the pre-season period between positions and correlates the data obtained from anthropometric equations with bioimpedance (BIA) measurements. Methods: Thirty-four female soccer players: 8 midfielders, 12 defenders, 11 forwards, and 3 goalkeepers (age: 23.06 ± 4.29 years, height: 164.15 ± 5.84 cm, weight: 58.39 ± 6.62 kg, and ∑6 skinfolds: 74.57 ± 18.48 mm) completed the study that lasted 4 weeks (pre-season) where they were measured anthropometrically and by bioimpedance twice. Results: Goalkeepers showed greater wingspan (176.60 ± 7.06 p < 0.05) compared to other positions. Regarding differences during pre-season, midfielders had the greatest decrease in ∑6 skinfolds compared to other positions (∆ −12.10 ± 5.69 p < 0.05). There was a correlation of % fat between Faulkner’s equation and BIA (Pearson’s r = 0.817). Conclusions: It seems that there are no significant differences in terms of positions and body composition, except for the wingspan and ankle diameter. During pre-season, midfielders are the ones who improve their body composition the greatest. The anthropometric equation for body fat that shows the highest correlation with BIA is Faulkner’s equation, followed by Durnin’s equation.
- Published
- 2024
- Full Text
- View/download PDF
6. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing
- Author
-
Agúndez José AG, Arcusa Àngels, Mañé Begoña, Martí Isabel, Dias Miguel, Gamundi María, Hernan Imma, Jurado Ismael, Borràs Emma, Blanca Miguel, and Carballo Miguel
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Epidermal growth factor receptor (EGFR) and its downstream factors KRAS and BRAF are mutated in several types of cancer, affecting the clinical response to EGFR inhibitors. Mutations in the EGFR kinase domain predict sensitivity to the tyrosine kinase inhibitors gefitinib and erlotinib in lung adenocarcinoma, while activating point mutations in KRAS and BRAF confer resistance to the anti-EGFR monoclonal antibody cetuximab in colorectal cancer. The development of new generation methods for systematic mutation screening of these genes will allow more appropriate therapeutic choices. Methods We describe a high resolution melting (HRM) assay for mutation detection in EGFR exons 19-21, KRAS codon 12/13 and BRAF V600 using formalin-fixed paraffin-embedded samples. Somatic variation of KRAS exon 2 was also analysed by massively parallel pyrosequencing of amplicons with the GS Junior 454 platform. Results We tested 120 routine diagnostic specimens from patients with colorectal or lung cancer. Mutations in KRAS, BRAF and EGFR were observed in 41.9%, 13.0% and 11.1% of the overall samples, respectively, being mutually exclusive. For KRAS, six types of substitutions were detected (17 G12D, 9 G13D, 7 G12C, 2 G12A, 2 G12V, 2 G12S), while V600E accounted for all the BRAF activating mutations. Regarding EGFR, two cases showed exon 19 deletions (delE746-A750 and delE746-T751insA) and another two substitutions in exon 21 (one showed L858R with the resistance mutation T590M in exon 20, and the other had P848L mutation). Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens. Ultra-deep amplicon pyrosequencing successfully validated the HRM results and allowed detection and quantitation of KRAS somatic mutations. Conclusions HRM is a rapid and sensitive method for moderate-throughput cost-effective screening of oncogene mutations in clinical samples. Rather than Sanger sequence validation, next-generation sequencing technology results in more accurate quantitative results in somatic variation and can be achieved at a higher throughput scale.
- Published
- 2011
- Full Text
- View/download PDF
7. Ginger in the Prevention of Cardiovascular Diseases
- Author
-
Cerdá, Begoña, primary, Marhuenda, Javier, additional, Arcusa, Raúl, additional, Villaño, Débora, additional, Ballester, Purificación, additional, and Zafrilla, Pilar, additional
- Published
- 2022
- Full Text
- View/download PDF
8. Food as a Dietary Source of Melatonin and Its Role in Human Health: Present and Future Perspectives
- Author
-
Ballester, Purificación, primary, Zafrilla, Pilar, additional, Arcusa, Raúl, additional, Galindo, Alejandro, additional, Cerdá, Begoña, additional, and Marhuenda, Javier, additional
- Published
- 2022
- Full Text
- View/download PDF
9. A Bayesian approach to integrating radiometric dating and varve measurements in intermittently indistinct sediment
- Author
-
S. H. Arcusa, N. P. McKay, C. Wiman, S. Patterson, S. E. Munoz, and M. A. Aquino-López
- Subjects
Geology ,QE1-996.5 ,Stratigraphy ,QE640-699 - Abstract
Annually laminated lake sediment can track paleoenvironmental change at high resolution where alternative archives are often not available. However, information about the chronology is often affected by indistinct and intermittent laminations. Traditional chronology building struggles with these kinds of laminations, typically failing to adequately estimate uncertainty or discarding the information recorded in the laminations entirely, despite their potential to improve chronologies. We present an approach that overcomes the challenge of indistinct or intermediate laminations and other obstacles by using a quantitative lamination quality index combined with a multi-core, multi-observer Bayesian lamination sedimentation model that quantifies realistic under- and over-counting uncertainties while integrating information from radiometric measurements (210Pb, 137Cs, and 14C) into the chronology. We demonstrate this approach on sediment of indistinct and intermittently laminated sequences from alpine Columbine Lake, Colorado. The integrated model indicates 3137 (95 % highest probability density range: 2753–3375) varve years with a cumulative posterior distribution of counting uncertainties of −13 % to +7 %, indicative of systematic observer under-counting. Our novel approach provides a realistic constraint on sedimentation rates and quantifies uncertainty in the varve chronology by quantifying over- and under-counting uncertainties related to observer bias as well as the quality and variability of the sediment appearance. The approach permits the construction of a chronology and sedimentation rates for sites with intermittent or indistinct laminations, which are likely more prevalent than sequences with distinct laminations, especially when considering non-lacustrine sequences, and thus expands the possibilities of reconstructing past environmental change with high resolution.
- Published
- 2022
- Full Text
- View/download PDF
10. Effectiveness of a polyphenolic extract (Lippia citriodora and Hibiscus sabdariffa) on appetite regulation in overweight and obese grade I population: an 8-week randomized, double-blind, cross-over, placebo-controlled trial
- Author
-
Serna, Ana, Marhuenda, Javier, Arcusa, Raúl, Pérez-Piñero, Silvia, Sánchez-Macarro, Maravillas, García-Muñoz, Ana María, Victoria-Montesinos, Desirée, Cánovas, Fernando, and López-Román, F. Javier
- Published
- 2022
- Full Text
- View/download PDF
11. The first otologic surgery in a skull from El Pendón site (Reinoso, Northern Spain)
- Author
-
Díaz-Navarro, Sonia, Tejedor-Rodríguez, Cristina, Arcusa-Magallón, Héctor, Pastor-Vázquez, Juan Francisco, Santos-Pérez, Jaime, Sánchez-Lite, Israel, Gibaja-Bao, Juan Francisco, García-González, Rebeca, and Rojo-Guerra, Manuel
- Published
- 2022
- Full Text
- View/download PDF
12. The impact of Holocene deglaciation and glacial dynamics on the landscapes and geomorphology of Potter Peninsula, King George Island (Isla 25 Mayo), NW Antarctic Peninsula
- Author
-
Pablo A. Heredia Barión, Jorge A. Strelin, Stephen J. Roberts, Cornelia Spiegel, Lukas Wacker, Samuel Niedermann, Michael J. Bentley, Emma J. Pearson, Nadia T. Manograsso Czalbowski, Sarah J. Davies, Bernhard Schnetger, Martin Grosjean, Stephanie Arcusa, Bianca Perren, Emma P. Hocking, and Gerhard Kuhn
- Subjects
deglaciation ,geomorphological mapping ,radiocarbon dating ,South Shetland islands ,stratigraphy ,glacier readvance ,Science - Abstract
The timing and impact of deglaciation and Holocene readvances on the terrestrial continental margins of the Antarctic Peninsula (AP) have been well-studied but are still debated. Potter Peninsula on King George Island (KGI) (Isla 25 de Mayo), South Shetland Islands (SSI), NW Antarctic Peninsula, has a detailed assemblage of glacial landforms and stratigraphic exposures for constraining deglacial landscape development and glacier readvances. We undertook new morphostratigraphic mapping of the deglaciated foreland of the Warszawa Icefield, an outlet of the Bellingshausen (Collins) Ice Cap on Potter Peninsula, using satellite imagery and new lithofacies recognition and interpretations, combined with new chronostratigraphic analysis of stratigraphic sections, lake sediments, and moraine deposits. Results show that the deglaciation on Potter Peninsula began before c. 8.2 ka. Around c. 7.0 ka, the Warszawa Icefield and the marine-facing Fourcade Glacier readvanced across Potter Peninsula and to the outer part of Potter Cove. Evidence of further readvances on Potter Peninsula was absent until the Warszawa Icefield margin was landward of its present position on three occasions: c. 1.7–1.4 ka, after c. 0.7 ka (most likely c. 0.5–0.1 ka), and by 1956 CE. The timing of Holocene deglaciation and glacier fluctuations on Potter Peninsula are broadly coeval with other glacier- and ice-free areas on the SSI and the northern AP and likely driven by interactions between millennial–centennial-scale changes in solar insolation and irradiance, the southern westerlies, and the Southern Annular Mode.
- Published
- 2023
- Full Text
- View/download PDF
13. Electronic health records and patient registries in medical oncology departments in Spain
- Author
-
Ribelles, N., Alvarez-Lopez, I., Arcusa, A., Chacon, J. I., de la Haba, J., García-Corbacho, J., Garcia-Mata, J., Jara, C., Jerez, J. M., Lázaro-Quintela, M., Leon-Mateos, L., Ramirez-Merino, N., Tibau, A., and Garcia-Palomo, A.
- Published
- 2021
- Full Text
- View/download PDF
14. Effect of Black Garlic Consumption on Endothelial Function and Lipid Profile: A Before-and-After Study in Hypercholesterolemic and Non-Hypercholesterolemic Subjects
- Author
-
Débora Villaño, Javier Marhuenda, Raúl Arcusa, José Manuel Moreno-Rojas, Begoña Cerdá, Gema Pereira-Caro, and Pilar Zafrilla
- Subjects
cardiometabolic diseases (CMDs) ,nutrition strategies ,black garlic ,organosulfur compounds ,endothelial adhesion molecules ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Background: Black garlic is obtained from raw garlic (Allium sativum L.), by a fermentation process, under humidity and heat treatment, showing a high concentration of organosulfur compounds, which have been related to benefits in the prevention or delay of cardiovascular diseases (CVDs). The objective of the research was to evaluate whether long-term consumption of black garlic improves endothelial function and lipid profile in subjects with hypercholesterolemia. Methods: Single center, controlled clinical trial with two branches: Hypercholesterolemia vs. Healthy condition. Sixty-two subjects of both sexes were distributed in two groups, the hypercholesterolemia group (n = 31) (total cholesterol (TC) range 200–300 mg/dL and low-density lipoprotein (LDL)-cholesterol range 135–175 mg/dL) and the healthy group (n = 31). The intervention consisted of the ingestion of 4 cloves of black garlic (12 g) daily for 12 weeks. Results: significant increases in Apolipoprotein (Apo)A1 occurred in both groups: Hypercholesterolemia (Δ 11.8 mg/dL p < 0.001) vs Healthy (Δ 11.1 mg/dL p < 0.001). Besides, significant reductions for endothelial adhesion molecules monocyte chemoattractant protein-1 (MCP-1) (Δ −121.5 pg/mL p = 0.007 vs. Δ −56.3 pg/mL p = 0.015), intracellular adhesion molecule-1 (ICAM-1) (Δ −39.3 ng/mL p < 0.001 vs. Δ 63.5 ng/mL p < 0.001), and vascular cyto-adhesion molecule-1 (VCAM-1) (Δ −144.4 ng/mL p < 0.001 vs. Δ −83.4 ng/mL p = 0.061) were observed, for hypercholesterolemic and healthy subjects, respectively. Conclusions: These data show that black garlic consumption could improve some parameters related to endothelial function and lipid profile, which may have a favorable impact on the risk of CVDs, although more long-term studies are necessary to confirm.
- Published
- 2023
- Full Text
- View/download PDF
15. A multiproxy database of western North American Holocene paleoclimate records
- Author
-
C. C. Routson, D. S. Kaufman, N. P. McKay, M. P. Erb, S. H. Arcusa, K. J. Brown, M. E. Kirby, J. P. Marsicek, R. S. Anderson, G. Jiménez-Moreno, J. R. Rodysill, M. S. Lachniet, S. C. Fritz, J. R. Bennett, M. F. Goman, S. E. Metcalfe, J. M. Galloway, G. Schoups, D. B. Wahl, J. L. Morris, F. Staines-Urías, A. Dawson, B. N. Shuman, D. G. Gavin, J. S. Munroe, and B. F. Cumming
- Subjects
Environmental sciences ,GE1-350 ,Geology ,QE1-996.5 - Abstract
Holocene climate reconstructions are useful for understanding the diverse features and spatial heterogeneity of past and future climate change. Here we present a database of western North American Holocene paleoclimate records. The database gathers paleoclimate time series from 184 terrestrial and marine sites, including 381 individual proxy records. The records span at least 4000 of the last 12 000 years (median duration of 10 725 years) and have been screened for resolution, chronologic control, and climate sensitivity. Records were included that reflect temperature, hydroclimate, or circulation features. The database is shared in the machine readable Linked Paleo Data (LiPD) format and includes geochronologic data for generating site-level time-uncertain ensembles. This publicly accessible and curated collection of proxy paleoclimate records will have wide research applications, including, for example, investigations of the primary features of ocean–atmospheric circulation along the eastern margin of the North Pacific and the latitudinal response of climate to orbital changes. The database is available for download at https://doi.org/10.6084/m9.figshare.12863843.v1 (Routson and McKay, 2020).
- Published
- 2021
- Full Text
- View/download PDF
16. Antioxidant Activity in Extracts from Zingiberaceae Family: Cardamom, Turmeric, and Ginger
- Author
-
Pura Ballester, Begoña Cerdá, Raúl Arcusa, Ana María García-Muñoz, Javier Marhuenda, and Pilar Zafrilla
- Subjects
antioxidant activity ,Elettaria cardamomum L. Maton (cardamom) ,Curcuma longa L. (turmeric) ,Zingiber officinale Roscoe (ginger) ,bioactive compounds ,Organic chemistry ,QD241-441 - Abstract
An increase in life expectancy leads to a greater impact of chronic non-communicable diseases. This is even more remarkable in elder populations, to whom these become main determinants of health status, affecting mental and physical health, quality of life, and autonomy. Disease appearance is closely related to the levels of cellular oxidation, pointing out the importance of including foods in one’s diet that can prevent oxidative stress. Previous studies and clinical data suggest that some plant-based products can slow and reduce the cellular degradation associated with aging and age-related diseases. Many plants from one family present several applications that range from the food to the pharmaceutical industry due to their characteristic flavor and scents. The Zingiberaceae family, which includes cardamom, turmeric, and ginger, has bioactive compounds with antioxidant activities. They also have anti-inflammatory, antimicrobial, anticancer, and antiemetic activities and properties that help prevent cardiovascular and neurodegenerative diseases. These products are abundant sources of chemical substances, such as alkaloids, carbohydrates, proteins, phenolic acids, flavonoids, and diarylheptanoids. The main bioactive compounds found in this family (cardamom, turmeric, and ginger) are 1,8-cineole, α-terpinyl acetate, β-turmerone, and α-zingiberene. The present review gathers evidence surrounding the effects of dietary intake of extracts of the Zingiberaceae family and their underlying mechanisms of action. These extracts could be an adjuvant treatment for oxidative-stress-related pathologies. However, the bioavailability of these compounds needs to be optimized, and further research is needed to determine appropriate concentrations and their antioxidant effects in the body.
- Published
- 2023
- Full Text
- View/download PDF
17. Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Author
-
Raúl Arcusa, Juan Ángel Carillo, Begoña Cerdá, Thierry Durand, Ángel Gil-Izquierdo, Sonia Medina, Jean-Marie Galano, María Pilar Zafrilla, and Javier Marhuenda
- Subjects
lipid peroxidation ,oxylipins ,polyphenols ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Isoprostanes (IsoPs) are lipid peroxidation biomarkers that reveal the oxidative status of the organism without specifying which organs or tissues it occurs in. Similar compounds have recently been identified that can assess central nervous system (CNS) lipid peroxidation status, usually oxidated by reactive oxygen species. These compounds are the neuroprostanes (NeuroPs) derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the F2t-dihomo-isoprotanes derived from adrenic acid (AdA). The aim of the present investigation was to evaluate whether the long-term nutraceutical consumption of high polyphenolic contents (600 mg) from fruits (such as berries) and vegetables shows efficacy against CNS lipid peroxidation in urine biomarkers. A total of 92 subjects (47 females, 45 males, age 34 ± 11 years old, weight 73.10 ± 14.29 kg, height 1.72 ± 9 cm, body mass index (BMI) 24.40 ± 3.43 kg/m2) completed a randomized, cross-over, double-blind study after an intervention of two periods of 16 weeks consuming either extract (EXT) or placebo (PLA) separated by a 4-week washout period. The results showed significant reductions in three AdA-derived metabolites, namely, 17-epi-17-F2t-dihomo-IsoPs (Δ −1.65 ng/mL; p < 0.001), 17-F2t-dihomo-IsoPs (Δ −0.17 ng/mL; p < 0.015), and ent-7(RS)-7-F2t-dihomo-IsoPs (Δ −1.97 ng/mL; p < 0.001), and one DHA-derived metabolite, namely, 4-F4t-NeuroP (Δ −7.94 ng/mL; p < 0.001), after EXT consumption, which was not observed after PLA consumption. These data seem to show the effectiveness of the extract for preventing CNS lipid peroxidation, as determined by measurements of oxylipins in urine through Ultra-High-Performance Liquid Chromatography triple quadrupole tandem mass spectrometry (UHPLC-QqQ-ESI-MS/MS).
- Published
- 2023
- Full Text
- View/download PDF
18. Modeling frequency response of gm-boosted inductorless Common-Gate LNA.
- Author
-
Jorge Marqués-García, Alberto Arcusa-Puente, Antonio D. Martínez-Pérez, and Francisco Aznar
- Published
- 2022
- Full Text
- View/download PDF
19. Anthropometric and Body Composition Changes during Pre-Season of Spanish Professional Female Soccer Players According to Playing Position.
- Author
-
Ramírez-Munera, Marta, Arcusa, Raúl, López-Román, Francisco Javier, Victoria-Montesinos, Desirée, García-Muñoz, Ana María, Ávila-Gandía, Vicente, Pérez-Piñero, Silvia, and Marhuenda, Javier
- Abstract
Background: In professional soccer, body composition analysis is crucial to assess preparation and optimize performance. Different playing positions have different physical demands, which can lead to variations in body composition. However, there are few studies on women's soccer that consider the playing position. This study aims to fill that gap by examining position-specific differences in anthropometric and body composition characteristics among Spanish professional female soccer players at the beginning and end of pre-season. Furthermore, it investigates the possible changes during the pre-season period between positions and correlates the data obtained from anthropometric equations with bioimpedance (BIA) measurements. Methods: Thirty-four female soccer players: 8 midfielders, 12 defenders, 11 forwards, and 3 goalkeepers (age: 23.06 ± 4.29 years, height: 164.15 ± 5.84 cm, weight: 58.39 ± 6.62 kg, and ∑6 skinfolds: 74.57 ± 18.48 mm) completed the study that lasted 4 weeks (pre-season) where they were measured anthropometrically and by bioimpedance twice. Results: Goalkeepers showed greater wingspan (176.60 ± 7.06 p < 0.05) compared to other positions. Regarding differences during pre-season, midfielders had the greatest decrease in ∑6 skinfolds compared to other positions (∆ −12.10 ± 5.69 p < 0.05). There was a correlation of % fat between Faulkner's equation and BIA (Pearson's r = 0.817). Conclusions: It seems that there are no significant differences in terms of positions and body composition, except for the wingspan and ankle diameter. During pre-season, midfielders are the ones who improve their body composition the greatest. The anthropometric equation for body fat that shows the highest correlation with BIA is Faulkner's equation, followed by Durnin's equation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. LA VIDA ES UN ETERNO VOLVER
- Author
-
Arcusa, Ramón
- Published
- 2019
- Full Text
- View/download PDF
21. An Arctic watershed observatory at Lake Peters, Alaska: weather–glacier–river–lake system data for 2015–2018
- Author
-
E. Broadman, L. L. Thurston, E. Schiefer, N. P. McKay, D. Fortin, J. Geck, M. G. Loso, M. Nolan, S. H. Arcusa, C. W. Benson, R. A. Ellerbroek, M. P. Erb, C. C. Routson, C. Wiman, A. J. Wong, and D. S. Kaufman
- Subjects
Environmental sciences ,GE1-350 ,Geology ,QE1-996.5 - Abstract
Datasets from a 4-year monitoring effort at Lake Peters, a glacier-fed lake in Arctic Alaska, are described and presented with accompanying methods, biases, and corrections. Three meteorological stations documented air temperature, relative humidity, and rainfall at different elevations in the Lake Peters watershed. Data from ablation stake stations on Chamberlin Glacier were used to quantify glacial melt, and measurements from two hydrological stations were used to reconstruct continuous discharge for the primary inflows to Lake Peters, Carnivore and Chamberlin creeks. The lake's thermal structure was monitored using a network of temperature sensors on moorings, the lake's water level was recorded using pressure sensors, and sedimentary inputs to the lake were documented by sediment traps. We demonstrate the utility of these datasets by examining a flood event in July 2015, though other uses include studying intra- and inter-annual trends in this weather–glacier–river–lake system, contextualizing interpretations of lake sediment cores, and providing background for modeling studies. All DOI-referenced datasets described in this paper are archived at the National Science Foundation Arctic Data Center at the following overview web page for the project: https://arcticdata.io/catalog/view/urn:uuid:df1eace5-4dd7-4517-a985-e4113c631044 (last access: 13 October 2019; Kaufman et al., 2019f).
- Published
- 2019
- Full Text
- View/download PDF
22. Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients
- Author
-
Cambra, M. J., Moreno, F., Sanz, X., Anglada, L., Mollà, M., Reyes, V., Arenas, M., Pedro, A., Ballester, R., García, V., Casals, J., Cusidó, M., Jimenez, C., Escribà, J. M., Macià, M., Solé, J. M., Arcusa, A., Seguí, M. A., Gonzalez, S., Farrús, B., and Biete, A.
- Published
- 2020
- Full Text
- View/download PDF
23. Effect of Ginger on Inflammatory Diseases
- Author
-
Pura Ballester, Begoña Cerdá, Raúl Arcusa, Javier Marhuenda, Karen Yamedjeu, and Pilar Zafrilla
- Subjects
inflammatory diseases ,ginger ,bioactive compounds ,Organic chemistry ,QD241-441 - Abstract
Ulcerative colitis, Crohn’s disease, rheumatoid arthritis, psoriasis, and lupus erythematosus are some of common inflammatory diseases. These affections are highly disabling and share signals such as inflammatory sequences and immune dysregulation. The use of foods with anti-inflammatory properties such as ginger (Zingiber officinale Roscoe) could improve the quality of life of these patients. Ginger is a plant widely used and known by its bioactive compounds. There is enough evidence to prove that ginger possesses multiple biological activities, especially antioxidant and anti-inflammatory capacities. In this review, we summarize the current knowledge about the bioactive compounds of ginger and their role in the inflammatory process and its signaling pathways. We can conclude that the compounds 6-shoagol, zingerone, and 8-shoagol display promising results in human and animal models, reducing some of the main symptoms of some inflammatory diseases such as arthritis. For lupus, 6-gingerol demonstrated a protective attenuating neutrophil extracellular trap release in response to phosphodiesterase inhibition. Ginger decreases NF-kβ in psoriasis, and its short-term administration may be an alternative coadjuvant treatment. Ginger may exert a function of supplementation and protection against cancer. Furthermore, when receiving chemotherapy, ginger may reduce some symptoms of treatment (e.g., nausea).
- Published
- 2022
- Full Text
- View/download PDF
24. Anti-Inflammatory and Antioxidant Capacity of a Fruit and Vegetable-Based Nutraceutical Measured by Urinary Oxylipin Concentration in a Healthy Population: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Author
-
Raúl Arcusa, Juan Ángel Carrillo, Begoña Cerdá, Thierry Durand, Ángel Gil-Izquierdo, Sonia Medina, Jean-Marie Galano, Débora Villaño Valencia, Javier Marhuenda, and Pilar Zafrilla
- Subjects
oxidative stress ,metabolic syndrome ,inflammation ,metabolic diseases ,isoprostanes ,oxylipins ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Oxylipins, lipid biomarkers of inflammation are considered the gold standard method to evaluate the inflammatory and antioxidant status. The aim of the present study was to investigate whether the administration of a polyphenolic extract shot in the form of a nutraceutical was able to reduce inflammation, measured in urine markers. Ninety-two participants (45 males, 47 females, age 34 ± 11 years, weight 73.10 ± 14.29 kg, height 1.72 ± 9 cm, BMI 24.40 ± 3.43 kg/m2) completed the study after an intervention of two 16-week periods consuming extract or placebo separated by a 4-week washout period. The results showed significant differences in terms of reduction of different pro-inflammatory oxylipins (15-keto-PGF2α (from 0.90 ± 0.25 ng/mL to 0.74 ± 0.19 ng/mL p < 0.05), ent-PGF2α (from 1.59 ± 0.37 ng/mL to 1.44 ± 0.32 ng/mL p < 0.05), 2,3-dinor-15-F2t-Isop) (from 1.17 ± 0.35 ng/mL to 1.02 ± 0.27 ng/mL p < 0.05), in total oxylipins count (from 8.03 ± 1.86 ng/mL to 7.25 ± 1.23 ng/mL p < 0.05), and increase in PGE2 (from 1.02 ± 0.38 ng/mL to 1.26 ± 0.38 ng/mL p < 0.05) which has an anti-inflammatory character, after extract consumption compared to placebo. The available data seem to indicate that long-term consumption of a nutraceutical with high polyphenol content improves inflammation and oxidation parameters measured in urine, through UHPLC-QqQ-ESI-MS/MS.
- Published
- 2022
- Full Text
- View/download PDF
25. Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study
- Author
-
Lope, Virginia, Guerrero-Zotano, Ángel, Fernández de Larrea-Baz, Nerea, Antolín, Silvia, Benavent Viñuales, Marta, Bermejo, Begoña, Ruiz-Moreno, Emma, Baena-Cañada, José Manuel, París, Lorena, Antón, Antonio, Chacón, José Ignacio, Muñoz, Montserrat, García-Sáenz, José Angel, Olier, Clara, Sánchez Rovira, Pedro, Arcusa Lanza, Angels, González, Sonia, Brunet, Joan, Oltra, Amparo, Bezares, Susana, Rosell, Libertad, Pérez-Gómez, Beatriz, Pastor-Barriuso, Roberto, Martín, Miguel, and Pollán, Marina
- Published
- 2024
- Full Text
- View/download PDF
26. Vertical sheep mobility along the altitudinal gradient through stable isotope analyses in tooth molar bioapatite, meteoric water and pastures: A reference from the Ebro valley to the Central Pyrenees
- Author
-
Tornero, Carlos, Aguilera, Mónica, Ferrio, Juan Pedro, Arcusa, Héctor, Moreno-García, Marta, Garcia-Reig, Sheila, and Rojo-Guerra, Manuel
- Published
- 2018
- Full Text
- View/download PDF
27. Investigating Neolithic caprine husbandry in the Central Pyrenees: Insights from a multi-proxy study at Els Trocs cave (Bisaurri, Spain).
- Author
-
Cristina Tejedor-Rodríguez, Marta Moreno-García, Carlos Tornero, Alizé Hoffmann, Íñigo García-Martínez de Lagrán, Héctor Arcusa-Magallón, Rafael Garrido-Pena, José Ignacio Royo-Guillén, Sonia Díaz-Navarro, Leonor Peña-Chocarro, Kurt W Alt, and Manuel Rojo-Guerra
- Subjects
Medicine ,Science - Abstract
Sheep remains constitute the main archaeozoological evidence for the presence of Early Neolithic human groups in the highlands of the Southern Pyrenees but understanding the role of herding activities in the Neolithisation process of this mountain ecosystem calls for the analysis of large and well-dated faunal assemblages. Cova de Els Trocs (Bisaurri, Huesca, Spain), a cave located at 1564 m a.s.l on the southern slopes of the Central Pyrenees, is an excellent case study since it was seasonally occupied throughout the Neolithic (ca. 5312-2913 cal. BC) and more than 4000 caprine remains were recovered inside. The multi-proxy analytical approach here presented has allowed us to offer new data elaborating on vertical mobility practices and herd management dynamics as has not been attempted up until now within Neolithic high-mountain sites in the Iberian Peninsula. For the first time, δ18O and δ13C stable isotope analyses offer direct evidence on both the regular practice of altitudinal movements of sheep flocks and the extended breeding season of sheep. Autumn births are recorded from the second half of the fifth millennium cal. BC onwards. Age-at-death distributions illustrate the progressive decline in caprine perinatal mortality together with the rising survival rate of individuals older than six months of age and the larger frequency of adults. This trend alongside the 'off-season' lambing signal at the implementation of husbandry techniques over time, probably aiming to increase the size of the flocks and their productivity. Palaeoparasitological analyses of sediment samples document also the growing reliance on herding activities of the human groups visiting the Els Trocs cave throughout the Neolithic sequence. In sum, our work provides substantial arguments to conclude that the advanced herding management skills of the Early Neolithic communities arriving in Iberia facilitated the anthropisation process of the subalpine areas of the Central Pyrenees.
- Published
- 2021
- Full Text
- View/download PDF
28. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
- Author
-
C.E. Geyer, J.E. Garber, R.D. Gelber, G. Yothers, M. Taboada, L. Ross, P. Rastogi, K. Cui, A. Arahmani, G. Aktan, A.C. Armstrong, M. Arnedos, J. Balmaña, J. Bergh, J. Bliss, S. Delaloge, S.M. Domchek, A. Eisen, F. Elsafy, L.E. Fein, A. Fielding, J.M. Ford, S. Friedman, K.A. Gelmon, L. Gianni, M. Gnant, S.J. Hollingsworth, S.-A. Im, A. Jager, Ó. Þ Jóhannsson, S.R. Lakhani, W. Janni, B. Linderholm, T.-W. Liu, N. Loman, L. Korde, S. Loibl, P.C. Lucas, F. Marmé, E. Martinez de Dueñas, R. McConnell, K.-A. Phillips, M. Piccart, G. Rossi, R. Schmutzler, E. Senkus, Z. Shao, P. Sharma, C.F. Singer, T. Španić, E. Stickeler, M. Toi, T.A. Traina, G. Viale, G. Zoppoli, Y.H. Park, R. Yerushalmi, H. Yang, D. Pang, K.H. Jung, A. Mailliez, Z. Fan, I. Tennevet, J. Zhang, T. Nagy, G.S. Sonke, Q. Sun, M. Parton, M.A. Colleoni, M. Schmidt, A.M. Brufsky, W. Razaq, B. Kaufman, D. Cameron, C. Campbell, A.N.J. Tutt, Paul Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, Angsar Weltermann, Daniel Egle, Irene Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser-Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke, Mustafa Aydogdu, Christoph Thomssen, Joachim Rom, Christine Mau, Peter Fasching, Uwe-Jochen Göhring, Thorsten Kühn, Stefanie Noeding, Sherko Kümmel, John Hackmann, Elmar Stickeler, Abhishek Joshi, Joanna Dewar, Michael Friedlander, Kelly-Anne Phillips, Yoland Antill, Natasha Woodward, Ehtesham Abdi, Susan Tiley, Mathew George, David Boadle, Annabel Goodwin, Andre van der Westhuizen, George Kannourakis, Nicholas Murray, Nicole McCarthy, Judith Kroep, Maaike de Boer, Joan Heijns, Agnes Jager, Franciscus Erdkamp, Sandra Bakker, Gabe S. Sonke, Amer Sami, John Mackey, Catherine Prady, Andrea Eisen, Christine Desbiens, Erica Patocskai, Cristiano Ferrario, Karen Gelmon, Louise Bordeleau, Haji Chalchal, Saroj Niraula, null ido wolf, Elżbieta Senkus, François Duhoux, null Randal d’Hondt, Sylvie Luce, Daphné t’Kint de Roodenbeke, Konstantinos Papadimitriou, Marleen Borms, Claire Quaghebeur, William Jacot, Etienne Brain, Laurence Venat-Bouvet, Alain Lortholary, Zbigniew Nowecki, Fátima Cardoso, Richard Hayward, Santiago Bella, Mauricio Fernández Lazzaro, Norma Pilnik, Luis E. Fein, Cesar Blajman, Guillermo Lerzo, Mirta Varela, Juan Jose Zarba, Diego Kaen, Maria Victoria Constanzo, Joke Tio, Wulf Siggelkow, Christian Jackisch, Eva Maria Grischke, Dirk Zahm, Sara Tato-Varela, Sabine Schmatloch, Peter Klare, Andrea Stefek, Kerstin Rhiem, Oliver Hoffmann, Mustafa Deryal, Isolde Gröll, Peter Ledwon, Christoph Uleer, Petra Krabisch, Jochem Potenberg, Maren Darsow, Tjoung-Won Park-Simon, Heinz-Gert Höffkes, Till-Oliver Emde, Gerd Graffunder, Oliver Tomé, Dirk Forstmeyer, Jürgen Terhaag, Christoph Salat, Karin Kast, Steffi Weniger, Carsten Schreiber, Bernhard Heinrich, Max Dieterich, Michaela Penelope Wüllner, Raquel Andrés Conejero, José Ángel García Sáenz, Lourdes Calvo Martinez, Angels Arcusa Lanza, Serafín Morales Murillo, Fernando Henao Carrasco, Salvador Blanch Tormo, Isabel Álvarez López, Juan Ignacio Delgado Mingorance, Elena Álvarez Gomez, Marta Santisteban, Josefina Cruz Jurado, Vanesa Quiroga, Manuel Ruiz Borrego, Eduardo Martínez de Dueñas, Jose Enrique Alés Martínez, Juan De la Haba, Noelia Martínez Jañez, Álvaro Rodríguez Lescure, Antonio Antón Torres, Gema Llort Crusades, Santiago González-Santiago, Antonia Marquez Aragones, Ana Laura Ortega, Agusti Barnadas Molins, José Ignacio Chacón López-Muñiz, Miguel Martín Jiménez, Ana Santaballa Bertrán, César Rodríguez, Lucía González Cortijo, Elisabetta Cretella, Laura Cortesi, Enzo Maria Ruggeri, Claudio Verusio, Stefania Gori, Andrea Bonetti, Anna Maria Mosconi, Oskar Johannsson, Guy Jerusalem, Patrick Neven, Tünde Nagy, Graziella Pinotti, Marco A. Colleoni, Antonio Bernardo, Lorenzo Gianni, Eraldo Bucci, Laura Biganzoli, Konstantin Dedes, Urban Novak, Khalil Zaman, Jeremy Braybrooke, Matthew Winter, Daniel Rea, Muireann Kelleher, Sophie Barrett, Stephen Chan, Tamas Hickish, Jane Hurwitz, John Conibear, Apurna Jegannathen, Marina Parton, Andrew Tutt, Rozenn Allerton, Annabel Borley, Anne Armstrong, Ellen Copson, Nicola Levitt, Jean Abraham, Timothy Perren, Rebecca Roylance, Kazushige Ishida, Tatsuya Toyama, Norikazu Masuda, Junichiro Watanabe, Eriko Tokunaga, Takayuki Kinoshita, Yoshiaki Rai, Masahiro Takada, Yasuhiro Yanagita, Rikiya Nakamura, Takahiro Nakayama, Yasuto Naoi, Hiroji Iwata, Seigo Nakamura, Masato Takahashi, Kenjiro Aogi, Koichiro Tsugawa, Hirofumi Mukai, Toshimi Takano, Akihiko Osaki, Nobuaki Sato, Hideko Yamauchi, Yutaka Tokuda, Mitsuya Ito, Takeki Sugimoto, Shakeela W. Bahadur, Patricia A. Ganz, Min J. Lu, Monica M. Mita, James Waisman, Jonathan A. Polikoff, Melinda L. Telli, Samantha A. Seaward, J. Marie Suga, Lara N. Durna, Jennifer Fu Carney, Alex Menter, Ajithkumar Puthillath, Nitin Rohatgi, James H. Feusner, Kristie A. Bobolis, Peter D. Eisenberg, Derrick Wong, Virginia F. Borges, Alexander T. Urquhart, Erin W. Hofstatter, Edward C. McCarron, Claudine Isaacs, Pia Herbolsheimer, Ramya Varadarajan, Adam Raben, Ruby Anne E. Deveras, Frances Valdes-Albini, Reshma L. Mahtani, Jane L. Meisel, Bradley T. Sumrall, Cheryl F. Jones, Samuel N. Ofori, Kenneth N.M. Sumida, Mark Karwal, Deborah W. Wilbur, (Joe) Singh, David M. Spector, John Schallenkamp, Douglas E. Merkel, Shelly S. Lo, Pam G. Khosla, Massimo Cristofanilli, Lisa Flaum, Kent F. Hoskins, Melody A. Cobleigh, Elyse A. Lambiase, Olwen M. Hahn, Ira A. Oliff, Bryan A. Faller, James L. Wade, Nafisa D. Burhani, Amaryllis Gil, Harvey E. Einhorn, Anna M.V. Storniolo, Brian K. Chang, Maitri Kalra, Erwin L. Robin, Bilal Ansari, Priyanka Sharma, Shaker R. Dakhil, Richard L. Deming, John T. Cole, David S. Hanson, Augusto C. Ochoa, Judy E. Garber, Harvey Zimbler, Deborah K. Armstrong, Katherine H.R. Tkaczuk, David A. Riseberg, Brian M. O'Connor, Thomas H. Openshaw, Dana Zakalik, Cynthia M. Vakhariya, Anne F. Schott, Michael S. Simon, Thomas J. Doyle, Tareq Al Baghdadi, Amy VanderWoude, Patrick J. Flynn, Richard T. Zera, Bret E.B. Friday, Kathryn J. Ruddy, Ron Smith, null Ademuyiwa, Foluso Olabisi, Robert Ellis, Jay W. Carlson, null Marchello, Benjamin T, Edward A. Levine, Paul K. Marcom, Cameron B. Harkness, Antoinette R. Tan, William J. Charles, Charles S. Kuzma, Shonda Asaad, James E. Radford, Preston D. Steen, Madhu Unnikrishnan, Grant R. Seeger, Kirsten M.H. Leu, Mehmet S. Copur, Ralph J. Hauke, Gamini S. Soori, Bradley A. Arrick, Jennifer G. Reeder, Deborah L. Toppmeyer, Zoneddy R. Dayao, Sylvia Adams, Eleni Andreopoulou, Magnuson Allison, Jesus D. Anampa Mesias, Ruby Sharma, Bhuvaneswari Ramaswamy, Aaron T. Gerds, Robert R. Shenk, Howard M. Gross, Shruti Trehan, Wajeeha Razaq, Abdul H. Mansoor, Christie J. Hilton, Adam M. Brufsky, Chanh Huynh, Nabila Chowdhury, Susan M. Domchek, Elin R. Sigurdson, Terrence P. Cescon, Marc A. Rovito, Albert S. DeNittis, Victor G. Vogel, Thomas B. Julian, L.E. Boyle, Luis Baez-Diaz, Frank J. Brescia, John E. Doster, Robert D. Siegel, Lucas Wong, Tejal Patel, Julie R. Nangia, Catherine A. Jones, George M. Cannon, Harry D. Bear, Hetal Vachhani, Mary Wilkinson, Marie E. Wood, Fengting Yan, Xingwei Sui, Carol M. van Haelst, Jennifer M. Specht, Ying Zhuo, Rubina Qamar, Matthew L. Ryan, Abigail Stockham, Shamsuddin Virani, Arlene A. Gayle, Steven J. Jubelirer, Sobha Kurian, Mohamad A. Salkeni, Niklas Loman, Barbro Linderholm, Gustav Silander, Anna-Lotta Hallbeck, Anna von Wachenfeldt Väppling, Elsa Curtit, Catarina Cardoso, Sofia Braga, Miguel Abreu, Mafalda Casa-Nova, Mónica Nave, Eva María Ciruelos Gil, Judith Balmaña Gelpi, Adela Fernández Ortega, Josep Gumà Padró, Begoña Bermejo de las Heras, María González Cao, Juan Cueva Bañuelos, Jesús Alarcon Company, Gemma Viñas Villaró, Laura García Estevez, Jens Huober, Steffi Busch, Tanja Fehm, Antje Hahn, Andrea Grafe, Thomas Noesselt, Thomas Dewitz, Harald Wagner, Christina Bechtner, Michael Weigel, Hans-Christian Kolberg, Thomas Decker, Jörg Thomalla, Tobias Hesse, Nadia Harbeck, Jan Schröder Jens-Uwe Blohmer, Marc Wolf Sütterlin, Renske Altena, Chang-Fang Chiu, Shin-Cheh Chen, Ming-Feng Hou, Yuan-Ching Chang, Shang-Hung Chen, Shou-Tung Chen, Chiun-Sheng Huang, Dah-Cherng Yeh, Jyh-Cherng Yu, Ling-Ming Tseng, Wei-Pang Chung, Audrey Mailliez, Thierry Petit, Suzette Delaloge, Christelle Lévy, Philippe Dalivoust, Jean-Marc Extra, Marie-Ange Mouret-Reynier, Anne-Claire Hardy-Bessard, Hélène Simon, Tiffenn L'Haridon, Alice Mege, Sylvie Giacchetti, Camille Chakiba-Brugere, Alain Gratet, Virginie Pottier, Jean-Marc Ferrero, Isabelle Tennevet, Christophe Perrin, Jean-Luc Canon, Sofie Joris, Zhimin Shao, Binghe Xu, ZeFei Jiang, Qiang Sun, Kunwei Shen, Da Pang, Jin Zhang, Shui Wang, Hongjian Yang, Ning Liao, Hong Zheng, Peifen Fu, Chuangui Song, Yongsheng Wang, Zhimin Fan, Cuizhi Geng, Olivier Tredan, László Landherr, Bella Kaufman, Rinat Yerushalmi, Beatrice Uziely, Pierfranco Conte, Claudio Zamagni, Giampaolo Bianchini, Michelino De Laurentiis, Carlo Tondini, Vittorio Gebbia, Mariangela Ciccarese, Tomasz Sarosiek, Jacek Mackiewicz, Anna Słowińska, Ewa Kalinka, Tomasz Huzarski, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Jee Hyun Kim, Keun Seok Lee, Yeon Hee Park, Kyoung Eun Lee, Yee Soo Chae, Eun Kyung Cho, Institut Català de la Salut, [Geyer CE Jr] NRG Oncology/NSABP Foundation, Pittsburgh, USA. Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, USA. [Garber JE] Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. [Gelber RD] Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. Harvard T.H. Chan School of Public Health, Boston, USA. Frontier Science Foundation, Boston, USA. [Yothers G] NRG Oncology/NSABP Foundation, Pittsburgh, USA. Department of Biostatistics, University of Pittsburgh, Pittsburgh, USA. [Taboada M] Oncology Biometrics Department, AstraZeneca, Macclesfield, UK. [Ross L] Department of Data Management, Frontier Science (Scotland), Kincraig, Scotland, UK. [Balmaña J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Medical Oncology, Public Health, Virology, Department of Psychology, Education and Child Studies, Internal Medicine, General Practice, and Child and Adolescent Psychiatry / Psychology
- Subjects
Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES] ,Medicaments antineoplàstics - Ús terapèutic ,Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores] ,Breast Neoplasms ,Other subheadings::Other subheadings::/drug therapy [Other subheadings] ,olaparib ,Article ,breast cancer ,SDG 3 - Good Health and Well-being ,BRCA1/2 ,células::células germinativas [ANATOMÍA] ,Humans ,Other subheadings::/therapeutic use [Other subheadings] ,Cells::Germ Cells [ANATOMY] ,neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES] ,Otros calificadores::/uso terapéutico [Otros calificadores] ,BRCA1 Protein ,PARP inhibition ,acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS] ,adjuvant therapy ,Hematology ,Cèl·lules germinals ,Germ Cells ,Oncology ,Mama - Càncer - Tractament ,Phthalazines ,Female ,Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [CHEMICALS AND DRUGS] - Abstract
Adjuvant therapy; Breast cancer; Olaparib Terapia adyuvante; Cáncer de mama; Olaparib Teràpia adjuvant; Càncer de mama; Olaparib Background The randomized, double-blind OlympiA trial compared 1 year of the oral poly(adenosine diphosphate-ribose) polymerase inhibitor, olaparib, to matching placebo as adjuvant therapy for patients with pathogenic or likely pathogenic variants in germline BRCA1 or BRCA2 (gBRCA1/2pv) and high-risk, human epidermal growth factor receptor 2-negative, early breast cancer (EBC). The first pre-specified interim analysis (IA) previously demonstrated statistically significant improvement in invasive disease-free survival (IDFS) and distant disease-free survival (DDFS). The olaparib group had fewer deaths than the placebo group, but the difference did not reach statistical significance for overall survival (OS). We now report the pre-specified second IA of OS with updates of IDFS, DDFS, and safety. Patients and methods One thousand eight hundred and thirty-six patients were randomly assigned to olaparib or placebo following (neo)adjuvant chemotherapy, surgery, and radiation therapy if indicated. Endocrine therapy was given concurrently with study medication for hormone receptor-positive cancers. Statistical significance for OS at this IA required P < 0.015. Results With a median follow-up of 3.5 years, the second IA of OS demonstrated significant improvement in the olaparib group relative to the placebo group [hazard ratio 0.68; 98.5% confidence interval (CI) 0.47-0.97; P = 0.009]. Four-year OS was 89.8% in the olaparib group and 86.4% in the placebo group (Δ 3.4%, 95% CI −0.1% to 6.8%). Four-year IDFS for the olaparib group versus placebo group was 82.7% versus 75.4% (Δ 7.3%, 95% CI 3.0% to 11.5%) and 4-year DDFS was 86.5% versus 79.1% (Δ 7.4%, 95% CI 3.6% to 11.3%), respectively. Subset analyses for OS, IDFS, and DDFS demonstrated benefit across major subgroups. No new safety signals were identified including no new cases of acute myeloid leukemia or myelodysplastic syndrome. Conclusion With 3.5 years of median follow-up, OlympiA demonstrates statistically significant improvement in OS with adjuvant olaparib compared with placebo for gBRCA1/2pv-associated EBC and maintained improvements in the previously reported, statistically significant endpoints of IDFS and DDFS with no new safety signals. Funding for this work, which was conducted as a collaborative partnership among the Breast International Group, NRG Oncology, Frontier Science, AstraZeneca, and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, U.S.A. (MSD), was provided by the National Institutes of Health (grant numbers: U10CA 180868, UG1CA 189867, and U10CA 180822) and by AstraZeneca as part of an alliance between AstraZeneca and MSD. Provision of olaparib and placebo was from AstraZeneca.
- Published
- 2022
29. Effect of Black Garlic Consumption on Endothelial Function and Lipid Profile: A Before-and-After Study in Hypercholesterolemic and Non-Hypercholesterolemic Subjects
- Author
-
Villaño, Débora, primary, Marhuenda, Javier, additional, Arcusa, Raúl, additional, Moreno-Rojas, José Manuel, additional, Cerdá, Begoña, additional, Pereira-Caro, Gema, additional, and Zafrilla, Pilar, additional
- Published
- 2023
- Full Text
- View/download PDF
30. Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study
- Author
-
Fernández de Larrea-Baz, Nerea, Pérez-Gómez, Beatriz, Guerrero-Zotano, Ángel, Casas, Ana María, Bermejo, Begoña, Baena-Cañada, José Manuel, Antolin, Silvia, Sánchez-Rovira, Pedro, Ramos Vázquez, Manuel, Garcia-Sáenz, José Ángel, Antón, Antonio, Muñoz, Montserrat, de Juan, Ana, Jara, Carlos, Chacón, José Ignacio, Arcusa, Angels, Gil-Gil, Miguel, Adrover, Encarna, Oltra, Amparo, Brunet, Joan, González, Sonia, Bezares, Susana, Lope, Virginia, Martín, Miguel, and Pollán, Marina
- Published
- 2020
- Full Text
- View/download PDF
31. A massacre of early Neolithic farmers in the high Pyrenees at Els Trocs, Spain
- Author
-
Alt, Kurt W., Tejedor Rodríguez, Cristina, Nicklisch, Nicole, Roth, David, Szécsényi Nagy, Anna, Knipper, Corina, Lindauer, Susanne, Held, Petra, de Lagrán, Íñigo García Martínez, Schulz, Georg, Schuerch, Thomas, Thieringer, Florian, Brantner, Philipp, Brandt, Guido, Israel, Nicole, Arcusa Magallón, Héctor, Meyer, Christian, Mende, Balazs G., Enzmann, Frieder, Dresely, Veit, Ramsthaler, Frank, Guillén, José Ignacio Royo, Scheurer, Eva, López Montalvo, Esther, Garrido Pena, Rafael, Pichler, Sandra L., and Guerra, Manuel A. Rojo
- Published
- 2020
- Full Text
- View/download PDF
32. Sports Nutrition and Performance
- Author
-
Arcusa Saura, Raúl, primary, Pilar Zafrilla Rentero, María, additional, and Marhuenda Hernández, Javier, additional
- Published
- 2019
- Full Text
- View/download PDF
33. De la Meseta a los Pirineos: génesis, desarrollo y perspectivas de un proyecto multidisciplinar sobre la neolitización peninsular
- Author
-
Rojo-Guerra, Manuel Ángel, primary, Garrido-Pena, Rafael, additional, García-Martínez de Lagrán, Iñigo, additional, Tejedor-Rodríguez, Cristina, additional, Arcusa-Magallón, Héctor, additional, and Royo-Guillén, José I., additional
- Published
- 2018
- Full Text
- View/download PDF
34. Effects of a Fruit and Vegetable-Based Nutraceutical on Biomarkers of Inflammation and Oxidative Status in the Plasma of a Healthy Population: A Placebo-Controlled, Double-Blind, and Randomized Clinical Trial
- Author
-
Raúl Arcusa, Juan Ángel Carrillo, Raquel Xandri-Martínez, Begoña Cerdá, Débora Villaño, Javier Marhuenda, and María Pilar Zafrilla
- Subjects
polyphenol ,biomarkers ,oxidative stress ,fruit ,vegetable ,nutraceutical ,Organic chemistry ,QD241-441 - Abstract
There is scientific evidence of the positive effect of polyphenols from plant foods on inflammation and oxidative status. The aim of the present study was to investigate whether treatment with a high-polyphenolic nutraceutical reduces the plasmatic concentration of certain oxidative and inflammatory biomarkers in a healthy population. One hundred and eight subjects were selected and stratified by sex in the intervention group (n = 53) and the placebo group (n = 55). Ninety-two subjects completed the study after two 16-week treatment periods separated by a four-week washout period. The results revealed statistically significant differences in subjects treated with the polyphenolic extract compared to the placebo: A decrease in homocysteine, oxidized low-density lipoprotein (OxLDL), TNF-α, sTNFR1, and C-reactive protein (CRP). The most significant decrease was observed for OxLDL (from 78.98 ± 24.48 to 69.52 ± 15.64; p < 0.05) and CRP (from 1.50 ± 0.33 to 1.39 ± 0.37; p < 0.05), both showing significant differences compared to the placebo (p < 0.001). Moreover, catecholamines increased after the administration of the product under investigation, especially in the case of dopamine (from 15.43 ± 2.66 to 19.61 ± 5.73; p < 0.05). Therefore, the consumption of a nutraceutical based on fruit and vegetables with a high polyphenol content seems to improve the parameters related to health benefits (oxidative and inflammatory biomarkers), including remarkable changes in the expression of catecholamines.
- Published
- 2021
- Full Text
- View/download PDF
35. Snapshot of the Carbon Dioxide Removal certification and standards ecosystem (2021–2022)
- Author
-
Stephanie Arcusa and Starry Sprenkle-Hyppolite
- Subjects
Atmospheric Science ,Global and Planetary Change ,Environmental Science (miscellaneous) ,Management, Monitoring, Policy and Law - Abstract
Carbon Dioxide Removal (CDR) will be necessary to fulfil the hundreds of pledges to reach net-zero by 2050. As with any industry, standard methodologies and certification are crucial to guarantee successful and reliable activities. However, buyers and policymakers currently face challenges in evaluating the ecosystem of CDR certification. The issue is not with CDR, nor with individual certifications – some of which may be very robust – but with the lack of transparency in the overall ecosystem. To bring some clarity, we present a snapshot of the CDR certification and standards ecosystem for the year 2021-2022. We find a complex ecosystem with at least 30 standard developing organizations proposing at least 125 standard methodologies for carbon removal from 23 different CDR activities and selling 27 different versions of certification instruments in voluntary and compliance markets. This exercise reveals many more existing standards for nature-based than for engineering-based activities and more diversity from standards serving the voluntary rather than the compliance market. It also highlights a proliferation of standards for the same activity, and a plethora of activities without standards. The process revealed ambiguity on what constitutes carbon removal, with many standards certifying activities that remove CO2 already in the environment as well as activities that avoid or reduce new emissions by sequestering the carbon into reservoirs. This mapping highlights key gaps and potential starting points for reforms to strengthen the CDR certification industry; it also underscores the need for independent oversight.
- Published
- 2022
36. Antioxidant Activity in Extracts from Zingiberaceae Family: Cardamom, Turmeric, and Ginger
- Author
-
Ballester, Pura, primary, Cerdá, Begoña, additional, Arcusa, Raúl, additional, García-Muñoz, Ana María, additional, Marhuenda, Javier, additional, and Zafrilla, Pilar, additional
- Published
- 2023
- Full Text
- View/download PDF
37. 114P Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies
- Author
-
Lopez-Tarruella Cobo, S., primary, Pollán, M.A., additional, Conejero, R. Andrés, additional, Jimenez, M. Martin, additional, Tormo, S. Servitja, additional, Bermejo, B., additional, Torres, A. Anton, additional, Zotano, A.L. Guerrero, additional, Munoz, M., additional, Fernández-Morales, L.A., additional, Martinez del Prado, P., additional, Lopez, I. Alvarez, additional, Calvo-Martinez, L., additional, Rodríguez-Lescure, A., additional, Lanza, A. Arcusa, additional, Borrego, M. Ruiz, additional, Herranz, J., additional, Polonio, O., additional, Adrover, E., additional, and Sanchez, C. Jara, additional
- Published
- 2023
- Full Text
- View/download PDF
38. Supplemental Material from A PAM50-Based Chemoendocrine Score for Hormone Receptor–Positive Breast Cancer with an Intermediate Risk of Relapse
- Author
-
Prat, Aleix, primary, Lluch, Ana, primary, Turnbull, Arran K., primary, Dunbier, Anita K., primary, Calvo, Lourdes, primary, Albanell, Joan, primary, de la Haba-Rodríguez, Juan, primary, Arcusa, Angels, primary, Chacón, José Ignacio, primary, Sánchez-Rovira, Pedro, primary, Plazaola, Arrate, primary, Muñoz, Montserrat, primary, Paré, Laia, primary, Parker, Joel S., primary, Ribelles, Nuria, primary, Jimenez, Begoña, primary, Bin Aiderus, Abdul Aziz, primary, Caballero, Rosalía, primary, Adamo, Barbara, primary, Dowsett, Mitch, primary, Carrasco, Eva, primary, Martín, Miguel, primary, Dixon, J. Michael, primary, Perou, Charles M., primary, and Alba, Emilio, primary
- Published
- 2023
- Full Text
- View/download PDF
39. Disseny d'una gamma d'accessoris d'exterior per a furgonetes 4x4
- Author
-
Universitat Politècnica de Catalunya. Departament d’Enginyeria Gràfica i de Disseny, Bivac Camper & Overland, Ventura Miret, Jordi, Gómez Arcusa, Oriol, Universitat Politècnica de Catalunya. Departament d’Enginyeria Gràfica i de Disseny, Bivac Camper & Overland, Ventura Miret, Jordi, and Gómez Arcusa, Oriol
- Abstract
En aquest treball es dissenya una gamma d'accessoris d'exterior per a furgonetes 4x4 de gran tamany, per a una empresa del sector anomenada BIVAC CAMPER. Així doncs es porta a terme el disseny i fabricació de tres accessoris per a furgonetes com són: una baca, un portarodes i un portabicis. Tots ells segueixen una mateixa idea estètica que comparteix els valors i la imatge de l'empresa. Per un costat, per a cada un dels accessoris, es porta a terme el disseny inicial i posteriorment el seu desenvolupament en 3d, pensant en tot moment en el procés de fabricació, tenint en compte els recursos actuals de l'empresa. Per altra banda, es fa una explicació detallada de quin és el procés de fabricació i muntatge, per tal de poder fabricar els diferents productes de la manera més senzilla i efectiva possible. Una vegada s'han tingut els tres accessoris dissenyats i llestos per a la seva fabricació, l'empresa ha apostat per portar a terme la fabricació de la baca, que s'ha vengut a un client. Complint així un dels objectius del treball, que era fer-lo el màxim realista per poder implementar-lo i que fos útil per a l'empresa. En un futur s'espera que els altres 2 accessoris que de moment no s'han fabricat per diferents motius de l'empresa, també es puguin fabricar i conjuntament amb la baca ajudin a l'empresa a donar un pas endevant en el món de les camper
- Published
- 2023
40. Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Author
-
Arcusa, Raúl, Carillo, Juan Ángel, Cerdá, Begoña, Durand, Thierry, Gil-Izquierdo, Ángel, Medina, Sonia, Galano, Jean-Marie, Zafrilla, María Pilar, Marhuenda, Javier, Arcusa, Raúl, Carillo, Juan Ángel, Cerdá, Begoña, Durand, Thierry, Gil-Izquierdo, Ángel, Medina, Sonia, Galano, Jean-Marie, Zafrilla, María Pilar, and Marhuenda, Javier
- Abstract
Isoprostanes (IsoPs) are lipid peroxidation biomarkers that reveal the oxidative status of the organism without specifying which organs or tissues it occurs in. Similar compounds have recently been identified that can assess central nervous system (CNS) lipid peroxidation status, usually oxidated by reactive oxygen species. These compounds are the neuroprostanes (NeuroPs) derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the F2t-dihomo-isoprotanes derived from adrenic acid (AdA). The aim of the present investigation was to evaluate whether the long-term nutraceutical consumption of high polyphenolic contents (600 mg) from fruits (such as berries) and vegetables shows efficacy against CNS lipid peroxidation in urine biomarkers. A total of 92 subjects (47 females, 45 males, age 34 ± 11 years old, weight 73.10 ± 14.29 kg, height 1.72 ± 9 cm, body mass index (BMI) 24.40 ± 3.43 kg/m2) completed a randomized, cross-over, double-blind study after an intervention of two periods of 16 weeks consuming either extract (EXT) or placebo (PLA) separated by a 4-week washout period. The results showed significant reductions in three AdA-derived metabolites, namely, 17-epi-17-F2t-dihomo-IsoPs (Δ −1.65 ng/mL; p < 0.001), 17-F2t-dihomo-IsoPs (Δ −0.17 ng/mL; p < 0.015), and ent-7(RS)-7-F2t-dihomo-IsoPs (Δ −1.97 ng/mL; p < 0.001), and one DHA-derived metabolite, namely, 4-F4t-NeuroP (Δ −7.94 ng/mL; p < 0.001), after EXT consumption, which was not observed after PLA consumption. These data seem to show the effectiveness of the extract for preventing CNS lipid peroxidation, as determined by measurements of oxylipins in urine through Ultra-High-Performance Liquid Chromatography triple quadrupole tandem mass spectrometry (UHPLC-QqQ-ESI-MS/MS).
- Published
- 2023
41. The impact of Holocene deglaciation and glacial dynamics on the landscapes and geomorphology of Potter Peninsula, King George Island (Isla 25 Mayo), NW Antarctic Peninsula
- Author
-
Heredia Barión, Pablo A., Strelin, Jorge A., Roberts, Stephen J., Spiegel, Cornelia, Wacker, Lukas, Niedermann, Samuel, Bentley, Michael J., Pearson, Emma J., Manograsso Czalbowski, Tamara, Davies, Sarah J., Schnetger, Bernhard, Grosjean, Martin, Arcusa, Stephanie, Perren, Bianca, Kuhn, Gerhard, Heredia Barión, Pablo A., Strelin, Jorge A., Roberts, Stephen J., Spiegel, Cornelia, Wacker, Lukas, Niedermann, Samuel, Bentley, Michael J., Pearson, Emma J., Manograsso Czalbowski, Tamara, Davies, Sarah J., Schnetger, Bernhard, Grosjean, Martin, Arcusa, Stephanie, Perren, Bianca, and Kuhn, Gerhard
- Abstract
The timing and impact of deglaciation and Holocene readvances on the terrestrial continental margins of the Antarctic Peninsula (AP) have been well-studied but are still debated. Potter Peninsula on King George Island (KGI) (Isla 25 de Mayo), South Shetland Islands (SSI), NW Antarctic Peninsula, has a detailed assemblage of glacial landforms and stratigraphic exposures for constraining deglacial landscape development and glacier readvances. We undertook new morphostratigraphic mapping of the deglaciated foreland of the Warszawa Icefield, an outlet of the Bellingshausen (Collins) Ice Cap on Potter Peninsula, using satellite imagery and new lithofacies recognition and interpretations, combined with new chronostratigraphic analysis of stratigraphic sections, lake sediments, and moraine deposits. Results show that the deglaciation on Potter Peninsula began before c. 8.2 ka. Around c. 7.0 ka, the Warszawa Icefield and the marine-facing Fourcade Glacier readvanced across Potter Peninsula and to the outer part of Potter Cove. Evidence of further readvances on Potter Peninsula was absent until the Warszawa Icefield margin was landward of its present position on three occasions: c. 1.7–1.4 ka, after c. 0.7 ka (most likely c. 0.5–0.1 ka), and by 1956 CE. The timing of Holocene deglaciation and glacier fluctuations on Potter Peninsula are broadly coeval with other glacier- and ice-free areas on the SSI and the northern AP and likely driven by interactions between millennial–centennial-scale changes in solar insolation and irradiance, the southern westerlies, and the Southern Annular Mode.
- Published
- 2023
42. Fire effects on the ant community in areas of native and exotic vegetation
- Author
-
Juan Manuel Arcusa
- Subjects
Invasive species ,restoration ,grassland ,fire ,Zoology ,QL1-991 ,Ecology ,QH540-549.5 ,Natural history (General) ,QH1-278.5 - Abstract
Acacia melanoxylon is an invasive species of the mountain grassland of the southeastern part of the Buenos Aires province, Argentina. Fires are a natural disturbance, characteristic of the area, and favor the germination of this invasive plant. However, they are used as the first step in management systems for the Acacia species. Moreover, the use of ants in monitoring programs is very scarce for Argentina. The objectives of this work are: 1) to analyze the response and resilience capacity of native and invaded sites by A. melanoxylon after a fire for controlling this invasive species; 2) to detect groups of ants considered to be indicators of the recovery phase subsequent to the burning; and 3) to apply the concept of groups of disturbances, proposed by Roig and Espadaler, as an effective tool for monitoring. The sampling design consisted of three replicates of 10 pitfall traps for each environment, native and invaded. Ant species were grouped into functional groups, trophic guilds, and disturbance groups. The fire did not generate significant changes in the richness and abundance of ants in the mountain grassland. However, it generated a positive effect on the sites invaded by Acacia during the first year after the fire. The groups of minimum specialists of vegetation and the dominant Dolichoderinae are considered good bioindicators. Finally, the disturbance indicators can be considered reliable management tools if the biology of the species that compose it is known beforehand.
- Published
- 2019
- Full Text
- View/download PDF
43. Was the 4.2 ka event unusual in context of global Holocene climate variability?
- Author
-
Nicholas McKay, Darrell Kaufman, Stéphanie Arcusa, and Hannah Kolus
- Abstract
Abrupt climate changes are commonly observed between 4500 and 4000 years ago, and particular attention has been paid to the “4.2 ka event”, which now serves as a stratigraphic marker to subdivide the mid and late Holocene globally. However, proxy climate records are commonly marked by large, and often abrupt, changes in temperature and moisture throughout the Holocene, and it remains unclear how abrupt change in the mid-Holocene compares to changes throughout the epoch. Here, we assess how regional and global temperature and moisture changes between 4.5 and 4.0 ka compare with other major climate events across the Holocene, in particular the 8.2 ka event. To conduct this analysis objectively, we assess more than a 1000 previously published paleoclimate datasets that span all continents and oceans and include a wide variety of archive and proxy types. All of the data are open access, and the analyses were conducted using the open-source “Abrupt Change Toolkit in R (actR)” software package to determine the timing and significance of multiple types of abrupt change. These include excursion events (significant short-term deviations from the mean state), regime change events (significant rapid shifts in millennial-scale means) and trend change events (significant changes in the long-term trend). We detect multiple significant abrupt change events throughout the Holocene, and therefore evaluate the spatiotemporal significance of events against a null hypothesis of observed background variability. Events at 8.2 ka stand out as large spatiotemporally coherent excursions of temperature and moisture centered in the North Atlantic and globally significant. In contrast, although we detect multiple types of abrupt change in moisture and temperature during the between 4.5 and 4.0 ka, the event does not significantly exceed the expectation of occurrence from our robust null model nor stand out as a regionally coherent anomaly. These results suggest that local abrupt changes are common throughout the Holocene; many of these are regionally coherent, but few are hemispheric or global in extent.
- Published
- 2023
44. Supplemental Material from A PAM50-Based Chemoendocrine Score for Hormone Receptor–Positive Breast Cancer with an Intermediate Risk of Relapse
- Author
-
Emilio Alba, Charles M. Perou, J. Michael Dixon, Miguel Martín, Eva Carrasco, Mitch Dowsett, Barbara Adamo, Rosalía Caballero, Abdul Aziz Bin Aiderus, Begoña Jimenez, Nuria Ribelles, Joel S. Parker, Laia Paré, Montserrat Muñoz, Arrate Plazaola, Pedro Sánchez-Rovira, José Ignacio Chacón, Angels Arcusa, Juan de la Haba-Rodríguez, Joan Albanell, Lourdes Calvo, Anita K. Dunbier, Arran K. Turnbull, Ana Lluch, and Aleix Prat
- Abstract
Supplemental Methods, Tables and Figures Tables Table S1. CES association with chemotherapy sensitivity (measured as pCR) in the MDACC-based dataset. Table S2. CES association with chemotherapy sensitivity (measured as Residual Cancer Burden [RCB]) in the MDACC-based dataset. Model A. Table S3. CES association with chemotherapy sensitivity (measured as Residual Cancer Burden [RCB]) in the MDACC-based dataset. Model B. Table S4. Univariate association of CES and various signatures with chemotherapy sensitivity in HR+/HER2-negative disease from the MDACC-based dataset. Table S5. Association of CES and PAM50 Proliferation Signature with chemotherapy sensitivity in HR+/HER2-negative disease from the MDACC-based dataset. Table S6. Association of CES and CHEMOPRED Signature with chemotherapy sensitivity in HR+/HER2-negative disease from the MDACC-based dataset. Table S7. Association of CES and the proliferation component of the Genomic Health Index (GHI; OncotypeDX Recurrence Score) with chemotherapy sensitivity in HR+/HER2- negative disease from the MDACC-based dataset. Table S8. Association of CES and Genomic Grade Index (GGI) Signature with chemotherapy sensitivity in HR+/HER2-negative disease from the MDACC-based dataset. Table S9. Association of CES and SET index Signature with chemotherapy sensitivity in HR+/HER2-negative disease from the MDACC-based dataset. Table S10. Association of CES and RCBPRED Signature with chemotherapy sensitivity in HR+/HER2-negative disease from the MDACC-based dataset. Table S11. Association of CES and DLDA30 Signature with chemotherapy sensitivity in HR+/HER2-negative disease from the MDACC-based dataset. Table S12. Association of CES and ROR-P Signature with chemotherapy sensitivity in HR+/HER2-negative disease from the MDACC-based dataset. Table S13. Association of CES and Ki67 by IHC with chemotherapy sensitivity in HR+/HER2-negative disease of the Malaga cohort. 7 Table S14. Association of CES and PAM50 ROR with chemotherapy sensitivity in HR+/HER2-negative disease of the Malaga cohort. Table S15. CES association with endocrine sensitivity in the Marsden dataset (n=103). Table S16. CES association with endocrine sensitivity in the Marsden dataset within HER2-negative disease (n=89). Figures Fig. S1. Association of CES with Miller-Payne following chemotherapy in HR+/HER2- negative disease from the Malaga-based cohort. Fig. S2. CES association with endocrine sensitivity in the Edinburgh dataset (n=120). (A) Tumor volume changes of each patient and response classification. (B) Association of CES and other variables with response (defined as at least 70% reduction by 90 days) in the overall population. (C) Association of CES and other variables with response within HER2-negative disease. Fig. S3. Association of CES with pCR in the combined dataset from the MDACC- and Malaga-based cohorts.
- Published
- 2023
45. Data from A PAM50-Based Chemoendocrine Score for Hormone Receptor–Positive Breast Cancer with an Intermediate Risk of Relapse
- Author
-
Emilio Alba, Charles M. Perou, J. Michael Dixon, Miguel Martín, Eva Carrasco, Mitch Dowsett, Barbara Adamo, Rosalía Caballero, Abdul Aziz Bin Aiderus, Begoña Jimenez, Nuria Ribelles, Joel S. Parker, Laia Paré, Montserrat Muñoz, Arrate Plazaola, Pedro Sánchez-Rovira, José Ignacio Chacón, Angels Arcusa, Juan de la Haba-Rodríguez, Joan Albanell, Lourdes Calvo, Anita K. Dunbier, Arran K. Turnbull, Ana Lluch, and Aleix Prat
- Abstract
Purpose: Hormone receptor–positive (HR+) breast cancer is clinically and biologically heterogeneous, and subgroups with different prognostic and treatment sensitivities need to be identified.Experimental Design: Research-based PAM50 subtyping and expression of additional genes was performed on 63 patients with HR+/HER2− disease randomly assigned to neoadjuvant multiagent chemotherapy versus endocrine therapy in a phase II trial. The biology associated with treatment response was used to derive a PAM50-based chemoendocrine score (CES). CES's predictive ability was evaluated in 4 independent neoadjuvant data sets (n = 675) and 4 adjuvant data sets (n = 1,505). The association of CES, intrinsic biology, and PAM50 risk of relapse (ROR) was explored across 6,007 tumors.Results: Most genes associated with endocrine sensitivity were also found associated with chemotherapy resistance. In the chemotherapy test/validation data sets, CES was independently associated with pathologic complete response (pCR), even after adjusting for intrinsic subtype. pCR rates of the CES endocrine–sensitive (CES-E), uncertain (CES-U), and chemotherapy-sensitive (CES-C) groups in both data sets combined were 25%, 11%, and 2%, respectively. In the endocrine test/validation data sets, CES was independently associated with response. Compared with ROR, >90% of ROR-low and ROR-high tumors were identified as CES-E and CES-C, respectively; however, each CES group represented >25% of ROR-intermediate disease. In terms of survival outcome, CES-C was associated with poor relapse-free survival in patients with ROR-intermediate disease treated with either adjuvant endocrine therapy only or no adjuvant systemic therapy, but not in patients treated with (neo)adjuvant chemotherapy.Conclusions: CES is a genomic signature capable of estimating chemoendocrine sensitivity in HR+ breast cancer beyond intrinsic subtype and risk of relapse. Clin Cancer Res; 23(12); 3035–44. ©2016 AACR.
- Published
- 2023
46. Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
- Author
-
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, Gorka Alkorta-Aranburu, Jose Ramon Antunez-Lopez, Gema Moreno-Bueno, Jose Palacios, Alfonso Yubero, Raul Marquez, Alejandro Gallego, Ana Beatriz Sanchez-Heras, Jose Antonio Lopez-Guerrero, Cristina Perez-Segura, Pilar Barretina-Ginesta, Jesus Alarcon, Lydia Gaba, Antonia Marquez, Judit Matito, Juan Cueva, Isabel Palacio, Maria Iglesias, Angels Arcusa, Luisa Sanchez-Lorenzo, Eva Guerra-Alia, Ignacio Romero, Ana Vivancos, Institut Català de la Salut, [Garcia-Casado Z] Molecular Biology Department, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain. [Oaknin A] Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Mendiola M] Instituto de Investigacion Biomedica del Hospital La Paz (IdiPAZ), Madrid, Spain. Centro de Investigacion Biomedica en Red de Cáncer (CIBERONC) Instituto de Salud Carlos III, Madrid, Spain. [Alkorta-Aranburu G] CIMA LAB Diagnostics/Universidad de Navarra, Pamplona, Spain. [Antunez-Lopez JR] Molecular Biology Department, Hospital Clinico Universitario Santiago, Santiago, Spain. [Moreno-Bueno G] Centro de Investigacion Biomedica en Red de Cáncer (CIBERONC) Instituto de Salud Carlos III, Madrid, Spain. Fundacion MD Anderson, Madrid, Spain. Departamento de Bioquímica, Instituto de Investigaciones Biomedicas ‘Alberto Sols. Conexion Cancer (UAM-CSIC), Universidad Autonoma de Madrid (UAM), IdiPAZ, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus, AstraZeneca, [Garcia-Casado, Zaida] Fdn Inst Valenciano Oncol, Mol Biol Dept, Valencia 46009, Spain, [Antonio Lopez-Guerrero, Jose] Fdn Inst Valenciano Oncol, Mol Biol Dept, Valencia 46009, Spain, [Oaknin, Ana] Vall dHebron Inst Oncol, Med Oncol Dept, Barcelona 08035, Spain, [Mendiola, Marta] Inst Invest Biomed Hosp La Paz IdiPAZ, Madrid 28029, Spain, [Mendiola, Marta] Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain, [Moreno-Bueno, Gema] Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain, [Palacios, Jose] Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain, [Alkorta-Aranburu, Gorka] Univ Navarra, CIMA LAB Diagnost, Pamplona 31008, Spain, [Ramon Antunez-Lopez, Jose] Hosp Clin Univ Santiago, Mol Biol Dept, Santiago 15706, Spain, [Moreno-Bueno, Gema] Fdn MD Anderson, Madrid 28033, Spain, [Marquez, Raul] Fdn MD Anderson, Madrid 28033, Spain, [Moreno-Bueno, Gema] Univ Autonoma Madrid UAM, Inst Invest Biomed Alberto Sols Conex Canc UAM CS, Dept Bioquim, IdiPAZ, Madrid 28029, Spain, [Palacios, Jose] Hosp Univ Ramon Y Cajal, Pathol Dept, Madrid 28034, Spain, [Palacios, Jose] Alcala Univ, Fac Med, Madrid 28801, Spain, [Palacios, Jose] Inst Ramon Y Cajal Hlth Res IRYCIS, Madrid 28034, Spain, [Yubero, Alfonso] Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza 50009, Spain, [Gallego, Alejandro] Hosp Univ La Paz, Med Oncol Dept, Madrid 28029, Spain, [Beatriz Sanchez-Heras, Ana] Hosp Gen Univ Elche, Med Oncol Dept, Elche 03203, Spain, [Antonio Lopez-Guerrero, Jose] Univ Catolica Valencia, Valencia 46001, Spain, [Antonio Lopez-Guerrero, Jose] Unidad Mixta Invest Canc IVO CIPF, Valencia 46009, Spain, [Perez-Segura, Cristina] Hosp St Pau & Santa Tecla, Med Oncol Dept, Tarragona 43003, Spain, [Barretina-Ginesta, Pilar] Inst Catala dOncol Girona, Med Oncol Dept, Girona 17007, Spain, [Alarcon, Jesus] Hosp Univ Son Espases, Med Oncol Dept, Palma De Mallorca 07120, Spain, [Gaba, Lydia] Hosp Clin Barcelona, Med Oncol Dept, Barcelona 08036, Spain, [Marquez, Antonia] Reg & Virgen Victoria Univ Hosp, Med Oncol Interctr Unit, IBIMA, Malaga 29010, Spain, [Matito, Judit] Vall dHebron Inst Oncol VHIO, Canc Genom Lab, Barcelona 08035, Spain, [Vivancos, Ana] Vall dHebron Inst Oncol VHIO, Canc Genom Lab, Barcelona 08035, Spain, [Cueva, Juan] Hosp Clin Univ Santiago, Med Oncol Dept, Santiago 15706, Spain, [Palacio, Isabel] Hosp Univ Cent Asturias, Med Oncol Dept, Oviedo 33011, Spain, [Iglesias, Maria] Hosp Univ Son LLatzer, Med Oncol Dept, Palma De Mallorca 07198, Spain, [Arcusa, Angels] Hosp Terrassa, Med Oncol Dept, Terrassa 08227, Spain, [Sanchez-Lorenzo, Luisa] Clin Univ Navarra, Med Oncol Dept, Pamplona 31008, Spain, [Guerra-Alia, Eva] Hosp Univ Ramon Y Cajal, Med Oncol Dept, Madrid 28034, Spain, [Romero, Ignacio] Inst Valenciano Oncol, Med Oncol Dept, Valencia 46009, Spain, and Astra Zeneca Farmaceutica Spain SA
- Subjects
Standards ,Germline ,Survival ,Medicine (miscellaneous) ,Ovaris - Càncer - Aspectes genètics ,Guidelines ,neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas [ENFERMEDADES] ,Sequence variants ,Association ,Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Genetic Testing [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,Somatic mutations ,Ovarian cancer ,Other subheadings::Other subheadings::/genetics [Other subheadings] ,Chemotherapy ,Joint-consensus-recommendation ,Ring Test Trial ,Otros calificadores::Otros calificadores::/genética [Otros calificadores] ,Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms [DISEASES] ,Cromosomes humans - Anomalies - Diagnòstic ,diagnóstico::técnicas y procedimientos diagnósticos::técnicas de laboratorio clínico::pruebas genéticas [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,College ,BRCA mutations ,BRCA testing ,ovarian cancer ,NGS - Abstract
Germline and tumor BRCA testing constitutes a valuable tool for clinical decision-making in the management of epithelial ovarian cancer (EOC) patients. Tissue testing is able to identify both germline (g) and somatic (s) BRCA variants, but tissue preservation methods and the widespread implementation of NGS represent pre-analytical and analytical challenges that need to be managed. This study was carried out on a multicenter prospective GEICO cohort of EOC patients with known gBRCA status in order to determine the inter-laboratory reproducibility of tissue sBRCA testing. The study consisted of two independent experimental approaches, a bilateral comparison between two reference laboratories (RLs) testing 82 formalin-paraffin-embedded (FFPE) EOC samples each, and a Ring Test Trial (RTT) with five participating clinical laboratories (CLs) evaluating the performance of tissue BRCA testing in a total of nine samples. Importantly, labs employed their own locally adopted next-generation sequencing (NGS) analytical approach. BRCA mutation frequency in the RL sub-study cohort was 23.17%: 12 (63.1%) germline and 6 (31.6%) somatic. Concordance between the two RLs with respect to BRCA status was 84.2% (gBRCA 100%). The RTT study distributed a total of nine samples (three commercial synthetic human FFPE references, three FFPE, and three OC DNA) among five CLs. The median concordance detection rate among them was 64.7% (range: 35.3–70.6%). Analytical discrepancies were mainly due to the minimum variant allele frequency thresholds, bioinformatic pipeline filters, and downstream variant interpretation, some of them with consequences of clinical relevance. Our study demonstrates a wide range of concordance in the identification and interpretation of BRCA sequencing data, highlighting the relevance of establishing standard criteria for detecting, interpreting, and reporting BRCA variants., This research was funded by Astra Zéneca Farmacéutica Spain SA (Grant Number GEICO60-0).
- Published
- 2022
47. Effects of the Consumption of Low-Fat Cooked Ham with Reduced Salt Enriched with Antioxidants on the Improvement of Cardiovascular Health: A Randomized Clinical Trial
- Author
-
Desirée Victoria-Montesinos, Raúl Arcusa, Ana María García-Muñoz, Silvia Pérez-Piñero, Maravillas Sánchez-Macarro, Antonio Avellaneda, and Francisco Javier López-Román
- Subjects
antioxidants ,oxidized LDL ,cooked ham ,catechins ,hydroxytyrosol ,chlorogenic acid ,Nutrition. Foods and food supply ,TX341-641 - Abstract
The aim of the study was to analyze how cardiovascular risk factors can be modified using nutritionally improved cooked ham enriched with a pool of antioxidants to influence relevant metabolic targets. Sixty-five untreated subjects (49.2% males, 50.8% females, mean age 40.92 ± 9.03 years) with total cholesterol level ≥180 mg/dL or LDL cholesterol ≥130 mg/dL participated in a 8-weeks randomized, double-blind controlled trial. Participant in the intervention group (51.5% males, 48.5% females, mean age 41.6 ± 9.8 years and mean BMI 25.1 ± 3.6 kg/m2) consumed cooked ham enriched with antioxidants (100 g/d) and controls (49.9% males, 53.1% females, mean age 40.2 ± 8.3 years and mean BMI 26.3 ± 3.2 kg/m2) received placebo. At 8 weeks, oxidized LDL decreased significantly between experimental and placebo groups (p < 0.036). Experimental group differences were also significant (p < 0.05). Similar findings in malondialdehyde, total cholesterol, high-sensitivity C-reactive protein, and interleukin 6 were observed in the intervention group. Significant between-group differences in these variables were also found, except for total cholesterol and interleukin 6. The effects on inflammation and oxidation support the direct action of these antioxidants on the etiopathogenic factors of atheromatous plaque. We also observed an improvement in the lipid profiles among the subjects.
- Published
- 2021
- Full Text
- View/download PDF
48. A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of a Polyphenolic Extract (Hibiscus sabdariffa and Lippia citriodora) for Reducing Blood Pressure in Prehypertensive and Type 1 Hypertensive Subjects
- Author
-
Javier Marhuenda, Silvia Pérez-Piñero, Raúl Arcusa, Desirée Victoria-Montesinos, Fernando Cánovas, Maravillas Sánchez-Macarro, Ana María García-Muñoz, María Querol-Calderón, and Francisco Javier López-Román
- Subjects
Hibiscus sabdariffa ,Lippia citriodora ,polyphenol ,blood pressure ,hypertension ,Organic chemistry ,QD241-441 - Abstract
Hypertension is an important factor of cardiovascular diseases and contributes to their negative consequences including mortality. The World Health Organization estimated that 54% of strokes and 47% of cases of ischemic heart illness are related to high blood pressure. Recently, Hibiscus sabdariffa (HS) and Lippia citriodora (LC) have attracted scientific interest, and they are recognized for their high content of polyphenols as these may prevent several disease factors, such as hypertension. The aim of the present study is to determine if supplementation with an HS-LC blend (MetabolAid®) may be effective for the treatment of type 1 hypertensive sedentary populations. A total of 80 type 1 hypertensive subjects of both sexes were included in the study and were treated with placebo or the HS-LC extract, and both groups were treated over 84 days. The blood pressure (diastolic, systolic, and pulse pressure) was measured throughout the day, for each of the days of the study duration and determined using Ambulatory Blood Pressure Monitoring (ABPM). Physical activity was determined throughout the study to ensure similar conditions related to exercise. The results showed the capacity for reducing the blood pressure parameters in the case of the HS-LC extract. The daily consumption of the HS-LC extract but not the placebo over 84 days was able to reduce the daytime parameters related to blood pressure. The most remarkable results were observed in the measurements performed during the daytime, especially in the systolic blood pressure showing statistically significant variation.
- Published
- 2021
- Full Text
- View/download PDF
49. Melatonin in Wine and Beer: Beneficial Effects
- Author
-
Javier Marhuenda, Débora Villaño, Raúl Arcusa, and Pilar Zafrilla
- Subjects
melatonin ,wine ,beer ,polyphenols ,free radical ,Organic chemistry ,QD241-441 - Abstract
Melatonin is a hormone secreted in the pineal gland with several functions, especially regulation of circadian sleep cycle and the biological processes related to it. This review evaluates the bioavailability of melatonin and resulting metabolites, the presence of melatonin in wine and beer and factors that influence it, and finally the different benefits related to treatment with melatonin. When administered orally, melatonin is mainly absorbed in the rectum and the ileum; it has a half-life of about 0.45–1 h and is extensively inactivated in the liver by phase 2 enzymes. Melatonin (MEL) concentration varies from picograms to ng/mL in fermented beverages such as wine and beer, depending on the fermentation process. These low quantities, within a dietary intake, are enough to reach significant plasma concentrations of melatonin, and are thus able to exert beneficial effects. Melatonin has demonstrated antioxidant, anticarcinogenic, immunomodulatory and neuroprotective actions. These benefits are related to its free radical scavenging properties as well and the direct interaction with melatonin receptors, which are involved in complex intracellular signaling pathways, including inhibition of angiogenesis and cell proliferation, among others. In the present review, the current evidence on the effects of melatonin on different pathophysiological conditions is also discussed.
- Published
- 2021
- Full Text
- View/download PDF
50. Effects of Fruit and Vegetable-Based Nutraceutical on Cognitive Function in a Healthy Population: Placebo-Controlled, Double-Blind, and Randomized Clinical Trial
- Author
-
Juan Ángel Carrillo, Raúl Arcusa, María Pilar Zafrilla, and Javier Marhuenda
- Subjects
cognition ,polyphenols ,executive function ,memory ,attention ,Stroop ,Therapeutics. Pharmacology ,RM1-950 - Abstract
There is scientific evidence of the positive effect of polyphenols from plant foods on cognition, but not enough is known about the synergistic effect when multiple polyphenols are consumed and even less in a healthy non-elderly population. The aim of the present study is to investigate the possible effects of improvements in cognitive function in healthy people as a preparation based on micronized fruit and vegetables consumed. One hundred and eight subjects were selected, stratified by sex in the control intervention group (n = 53) and placebo (n = 55). Volunteers completed the study after two 16-week periods of consumption with a 4-week wash period between each phase. At the beginning and the end of each phase, volunteers performed the Stroop, TESEN, and RIST tests for the measurement of different cognitive function patterns. The results revealed statistically significant differences in all the variables of the tests carried out, especially compared with the placebo. Specially, the results obtained in the Stroop and TESEN test, in addition to the processing speed even with semantic interferences, were markedly better after the treatment with the product under study. Moreover, the consumption of the product under study clearly improves short-term memory, verbal and non-verbal, according to the results obtained in the RIST test. The results showed an improvement in executive function in terms of short-term memory, working memory, selective and sustained attention, and speed of processing.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.